DE3880231T2 - Pyrazinoxid-Verbindung aus NF-1616-904, diese enthaltende Arzneimittelzubereitung und Verfahren zu ihrer Herstellung. - Google Patents
Pyrazinoxid-Verbindung aus NF-1616-904, diese enthaltende Arzneimittelzubereitung und Verfahren zu ihrer Herstellung.Info
- Publication number
- DE3880231T2 DE3880231T2 DE88112999T DE3880231T DE3880231T2 DE 3880231 T2 DE3880231 T2 DE 3880231T2 DE 88112999 T DE88112999 T DE 88112999T DE 3880231 T DE3880231 T DE 3880231T DE 3880231 T2 DE3880231 T2 DE 3880231T2
- Authority
- DE
- Germany
- Prior art keywords
- preparation
- oxide compound
- pharmaceutical preparation
- pyrazine oxide
- preparation containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20153787 | 1987-08-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3880231D1 DE3880231D1 (de) | 1993-05-19 |
DE3880231T2 true DE3880231T2 (de) | 1993-10-07 |
Family
ID=16442692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE88112999T Expired - Fee Related DE3880231T2 (de) | 1987-08-11 | 1988-08-10 | Pyrazinoxid-Verbindung aus NF-1616-904, diese enthaltende Arzneimittelzubereitung und Verfahren zu ihrer Herstellung. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5021419A (de) |
EP (1) | EP0303250B1 (de) |
JP (1) | JPH01131177A (de) |
KR (1) | KR960005150B1 (de) |
CN (1) | CN1028655C (de) |
DE (1) | DE3880231T2 (de) |
DK (1) | DK170617B1 (de) |
ES (1) | ES2054748T3 (de) |
MX (1) | MX9202936A (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5238938A (en) * | 1989-02-10 | 1993-08-24 | Otsuka Pharmaceutical Co., Ltd. | Indole derivatives |
DE69029231T2 (de) | 1989-02-10 | 1997-03-20 | Otsuka Pharma Co Ltd | Indolderivate, ihre herstellung und diese enthaltendes arzneimittel zum verhindern und behandeln von nephritis |
JP2599665B2 (ja) * | 1991-05-01 | 1997-04-09 | 大塚製薬株式会社 | ピラジン誘導体 |
SE529897C2 (sv) | 2006-03-27 | 2007-12-27 | Rottneros Ab | Formpressat tråg |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8427735D0 (en) * | 1984-11-02 | 1984-12-12 | Fujisawa Pharmaceutical Co | Piperazine compound |
-
1988
- 1988-08-10 DE DE88112999T patent/DE3880231T2/de not_active Expired - Fee Related
- 1988-08-10 EP EP88112999A patent/EP0303250B1/de not_active Expired - Lifetime
- 1988-08-10 JP JP63200928A patent/JPH01131177A/ja active Granted
- 1988-08-10 ES ES88112999T patent/ES2054748T3/es not_active Expired - Lifetime
- 1988-08-10 DK DK446388A patent/DK170617B1/da not_active IP Right Cessation
- 1988-08-11 KR KR1019880010242A patent/KR960005150B1/ko not_active IP Right Cessation
- 1988-08-11 CN CN88104951A patent/CN1028655C/zh not_active Expired - Fee Related
-
1990
- 1990-05-07 US US07/518,252 patent/US5021419A/en not_active Expired - Fee Related
-
1992
- 1992-06-17 MX MX9202936A patent/MX9202936A/es unknown
Also Published As
Publication number | Publication date |
---|---|
DK170617B1 (da) | 1995-11-13 |
DK446388D0 (da) | 1988-08-10 |
MX9202936A (es) | 1992-06-30 |
DK446388A (da) | 1989-02-12 |
EP0303250A2 (de) | 1989-02-15 |
JPH01131177A (ja) | 1989-05-24 |
JPH0557273B2 (de) | 1993-08-23 |
CN1032031A (zh) | 1989-03-29 |
EP0303250B1 (de) | 1993-04-14 |
KR960005150B1 (ko) | 1996-04-22 |
ES2054748T3 (es) | 1994-08-16 |
KR890003734A (ko) | 1989-04-17 |
US5021419A (en) | 1991-06-04 |
DE3880231D1 (de) | 1993-05-19 |
EP0303250A3 (en) | 1990-07-11 |
CN1028655C (zh) | 1995-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE46900T1 (de) | Phenylethanolaminotetraline, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3582952D1 (de) | Dihydropyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE69105787T2 (de) | Polycyclische Verbindung, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel. | |
DE3381772D1 (de) | Substituierte azabicyclo-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3575724D1 (de) | Quinolizinon-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
DE3680877D1 (de) | Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE8892T1 (de) | Substituierte azabicyclooctancarboxylsaeure, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3881950D1 (de) | Azabicyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
ATE23152T1 (de) | Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel. | |
DE3766299D1 (de) | 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
DE3483308D1 (de) | Semicarbazid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3789466D1 (de) | 3,7-Disubstituierte-3-Cephemverbindungen und Verfahren zu ihrer Herstellung. | |
DE3880231T2 (de) | Pyrazinoxid-Verbindung aus NF-1616-904, diese enthaltende Arzneimittelzubereitung und Verfahren zu ihrer Herstellung. | |
DE3670638D1 (de) | Indol-3-yl-chinazolin-1,4-benzodiazepin-5,13-dione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
DE3481418D1 (de) | Substituierte spiropyridinderivate, diese enthaltende pharmazeutische zubereitungen, verfahren zu ihrer herstellung und zubereitungen. | |
DE3586817T2 (de) | 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3684803D1 (de) | Dihydropyridin-alkanolamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3773240D1 (de) | Hydrochinolinverbindungen, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung. | |
ATE84531T1 (de) | Guanidincarbonsaeureester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
DE3883886D1 (de) | 3-Sulfonyl-3,7-diazabicyclo-(3,3,1)nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel. | |
DE3575137D1 (de) | 9- beziehungsweise 11-(nitro)-apovincaminsaeurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
DE3787319D1 (de) | 1,4-Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. | |
DE3887626D1 (de) | 2-Oxa-isocephem-Verbindungen, diese enthaltende Zusammensetzungen und Verfahren zu deren Herstellung. | |
DE3675671D1 (de) | Substituierte 1,8-naphthyridinone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE58540T1 (de) | Substituierte 1,8-naphthyridinone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |